Risk factors for pneumonitis in advanced extrapulmonary cancer patients treated with immune checkpoi...
Risk factors for pneumonitis in advanced extrapulmonary cancer patients treated with immune checkpoint inhibitors
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Immune-mediated pneumonitis has a high mortality rate; however, information regarding the related risk factors remains limited. This study aimed to analyze risk factors for pneumonitis, including smoking and lung metastasis (LM), in patients with extrapulmonary primary tumors.
Data of 110 patients treated with immune checkpoint inhibitors (ICIs)...
Alternative Titles
Full title
Risk factors for pneumonitis in advanced extrapulmonary cancer patients treated with immune checkpoint inhibitors
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e05e74eb94344680973aa98b3bcd0672
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e05e74eb94344680973aa98b3bcd0672
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/s12885-022-09642-w
